Researchers
Vučićević, Katarina
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2022 | Application of adjusted indirect comparisons to assess bioequivalence and switchability between generic drugs – example of clopidogrel | Pejčić, Zorica; Vučićević, Katarina ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Zabrinutost u vezi sa primenom lekova kod pacijenata sa hroničnim respiratornim oboljenjima | Kovačević, Milena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Introduction of an Objective Structured Clinical Examination for Pharmacy Students in Serbia | Vezmar-Kovačević, Sandra ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Procena terapije i komorbiditeta kod pacijenata sa hroničnom opstruktivnom bolešću pluća | Marković, Aleksandra ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Procena tehnike inhalacije farmaceuta u primarnoj zdravstvenoj zaštiti ‐ fokus na inhalatore za suvi prašak | Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Analysis of clozapine and norclozapine concentrations in adult patients with schizophrenia | Panić, Bojana; Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Assessment of cyclosporin A exposure and identification of variability factors in the early posttransplantation period (✓) | Roganović, Maša ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Community pharmacist-driven interventions in COPD: improving knowledge, attitude and health status | Ćulafić, Milica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2022 | Assessment of pembrolizumab exposure in different patient subpopulations using pharmacometric simulation | Homšek, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Pediatric pharmacokinetic considerations and implications for drug dosing | Jovanović, Marija ![]() ![]() ![]() ![]() | Article | 52M52 |
2022 | Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis (PrEP) Clinical Trials | Garcia-Cremades, Maria; Vučićević, Katarina ![]() ![]()
Anderson, Peter; Choopanya, Kachit; Vanichseni, Suphak; Glidden, David V.; Savić, Radojka M.;
| Article | 21aM21a |
2022 | Percepcija farmaceuta o pružanju usluge pacijentima sa glavoboljom u primarnoj zdravstvenoj zaštiti | Homšek, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Praćenje interakcija lekova kod starijih pacijenata sa benignom hiperplazijom prostate i kardiovaskularnim oboljenjima | Lazarević, Katarina; Marković, Aleksandra ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | Population pharmacokinetic-pharmacogenetic (PopPK-PGx) model of efavirez in HIV-1-infected Serbian patients | Vučićević, Katarina ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | Population exposure-response model of 131I in patients with benign thyroid disease | Topić-Vučenović, Valentina; Rajkovača, Zvezdana; Jelić, Dijana; Stanimirović, Dragi; Mikov, Momir ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2021 | Concept and utility of population pharmacokinetic and pharmacokinetic/ pharmacodynamic models in drug development and clinical practice | Roganović, Maša ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 52M52 |
2021 | The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach | Topić Vučenović, Valentina; Rajkovača, Zvezdana; Jelić, Dijana; Stanimirović, Dragi; Mikov, Momir; Miljković, Branislava ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | Population pharmacokinetic modelling of cyclosporine in paediatric kidney transplant patients using routine TDM data (✓) | Roganović, Maša ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2021 | A Mechanistic In Vivo/Ex Vivo Pharmacokinetic-Pharmacodynamic Model of Tenofovir for HIV Prevention | Jayachandran, Priya; Garcia-Cremades, Maria; Vučićević, Katarina ![]() ![]() | Article | 21M21 |
2021 | Predicting Hiv Risk and Protective Tenofovir Concentration: a Pooled Analysis from Hiv Pre-Exposure Prophylaxis Trials. | Garcia-Cremades, Maria; ...; Vucicevic, Katarina M ![]() ![]() | Conference Paper | Mp. category will be shown later |